Gwen Melincoff

Advisory Board Member at Verge Genomics

Gwen Melincoff is the Vice President, Business Development at BTG plc. Previously she was Senior Vice President at Shire Strategic Investment Group, where she was a key force behind many of Shire's M&A and technology licensing agreements, and she has played a crucial role in helping the global specialty biopharmaceutical company grow. Through her former position as head of Shire's Strategic Investment Group and in other business development executive roles at the company, she's helped expand Shire's reach and product roster a number of times.

Timeline

  • Advisory Board Member

    Current role